254 related articles for article (PubMed ID: 19813185)
41. The association between the metabolic syndrome and alanine amino transferase is mediated by insulin resistance via related metabolic intermediates (the Cohort on Diabetes and Atherosclerosis Maastricht [CODAM] study).
Jacobs M; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer C
Metabolism; 2011 Jul; 60(7):969-75. PubMed ID: 21040936
[TBL] [Abstract][Full Text] [Related]
42. From the metabolic syndrome to NAFLD or vice versa?
Vanni E; Bugianesi E; Kotronen A; De Minicis S; Yki-Järvinen H; Svegliati-Baroni G
Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596
[TBL] [Abstract][Full Text] [Related]
43. Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance.
Yilmaz Y; Ulukaya E; Atug O; Dolar E
Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1247-51. PubMed ID: 19474742
[TBL] [Abstract][Full Text] [Related]
44. Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome.
Yilmaz Y; Senates E; Ayyildiz T; Colak Y; Tuncer I; Ovunc AO; Dolar E; Kalayci C
Eur J Clin Invest; 2012 Apr; 42(4):411-8. PubMed ID: 21913918
[TBL] [Abstract][Full Text] [Related]
45. Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis.
Yilmaz Y; Alahdab YO; Yonal O; Kurt R; Kedrah AE; Celikel CA; Ozdogan O; Duman D; Imeryuz N; Avsar E; Kalayci C
Metabolism; 2010 Sep; 59(9):1327-30. PubMed ID: 20096896
[TBL] [Abstract][Full Text] [Related]
46. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease.
Pirgon O; Bilgin H; Tolu I; Odabas D
Clin Endocrinol (Oxf); 2011 Aug; 75(2):189-95. PubMed ID: 21521307
[TBL] [Abstract][Full Text] [Related]
47. Aortic elastic properties in nonalcoholic fatty liver disease.
Fotbolcu H; Yakar T; Duman D; Ozden K; Karaahmet T; Tigen K; Kurtoglu U; Dindar I
Blood Press Monit; 2010 Jun; 15(3):139-45. PubMed ID: 20414104
[TBL] [Abstract][Full Text] [Related]
48. The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome.
Cheung O; Kapoor A; Puri P; Sistrun S; Luketic VA; Sargeant CC; Contos MJ; Shiffman ML; Stravitz RT; Sterling RK; Sanyal AJ
Hepatology; 2007 Oct; 46(4):1091-100. PubMed ID: 17610277
[TBL] [Abstract][Full Text] [Related]
49. Nonalcoholic fatty liver disease: a challenge for pediatricians.
Widhalm K; Ghods E
Int J Obes (Lond); 2010 Oct; 34(10):1451-67. PubMed ID: 20838401
[TBL] [Abstract][Full Text] [Related]
50. Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension.
Francque S; Verrijken A; Mertens I; Hubens G; Van Marck E; Pelckmans P; Michielsen P; Van Gaal L
Int J Obes (Lond); 2011 Feb; 35(2):270-8. PubMed ID: 20661251
[TBL] [Abstract][Full Text] [Related]
51. Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver disease.
Trovato GM; Martines GF; Pirri C; Trovato FM; Castro A; Garozzo A; Catalano D
J Clin Gastroenterol; 2012 Jul; 46(6):e46-54. PubMed ID: 22476041
[TBL] [Abstract][Full Text] [Related]
52. IGF-1 levels in different stages of liver steatosis and its association with metabolic syndrome.
Mallea-Gil MS; Ballarino MC; Spiraquis A; Iriarte M; Kura M; Gimenez S; Oneto A; Guitelman M; Machado R; Miguel CM
Acta Gastroenterol Latinoam; 2012 Mar; 42(1):20-6. PubMed ID: 22616493
[TBL] [Abstract][Full Text] [Related]
53. The epidemiology, pathogenesis and histopathology of fatty liver disease.
Levene AP; Goldin RD
Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
[TBL] [Abstract][Full Text] [Related]
54. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.
Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
J Clin Gastroenterol; 2006 Sep; 40(8):745-52. PubMed ID: 16940890
[TBL] [Abstract][Full Text] [Related]
55. Frequency of metabolic syndrome and 25-hydroxyvitamin D3 levels in patients with non-alcoholic fatty liver disease.
Eraslan S; Kizilgul M; Uzunlulu M; Colak Y; Ozturk O; Tuncer I
Minerva Med; 2013 Aug; 104(4):447-53. PubMed ID: 24008607
[TBL] [Abstract][Full Text] [Related]
56. Fatty liver disease in obese children--relation to other metabolic risk factors.
Volovelsky O; Weiss R
Int J Pediatr Obes; 2011 Sep; 6 Suppl 1():59-64. PubMed ID: 21905818
[TBL] [Abstract][Full Text] [Related]
57. Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation.
Tilg H; Moschen A
Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):391-6. PubMed ID: 20473151
[TBL] [Abstract][Full Text] [Related]
58. Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease.
Manchanayake J; Chitturi S; Nolan C; Farrell GC
J Gastroenterol Hepatol; 2011 Mar; 26(3):510-6. PubMed ID: 21155882
[TBL] [Abstract][Full Text] [Related]
59. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).
Kalra S; Vithalani M; Gulati G; Kulkarni CM; Kadam Y; Pallivathukkal J; Das B; Sahay R; Modi KD
J Assoc Physicians India; 2013 Jul; 61(7):448-53. PubMed ID: 24772746
[TBL] [Abstract][Full Text] [Related]
60. NAFLD in the absence of metabolic syndrome: different epidemiology, pathogenetic mechanisms, risk factors for disease progression?
Yilmaz Y
Semin Liver Dis; 2012 Feb; 32(1):14-21. PubMed ID: 22418884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
